GLP-1 receptor agonists, as established in earlier sections, independently produce average weight reductions of 15 to 22% of total body weight in the STEP and SURMOUNT trial programs [8,9]
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight
Digestive side effects such as nausea, bloating, and constipation are typically most pronounced when starting Ozempic or increasing the dose, and usually improve over several weeks as your body adapts to the medication
Switching from semaglutide to tirzepatide requires careful medical supervision with proper washout periods and gradual dose escalation to maximize the enhanced weight loss benefits while minimizing side effects
Yes, HSA funds can potentially cover semaglutide injections, but eligibility depends on your specific plan, the diagnosis code provided by your healthcare provider, and whether the medication is deemed medically necessary rather than elective